Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. [electronic resource]
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy Apr 2000
- 267-77 p. digital